A morning dose aligns with the bodys natural detox cycle
Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
Instead, focus on healthy foods high in fiber and protein, such as whole grains, vegetables, fruits, legumes, and quality protein sources like fish, chicken breast, and tofu
Currently, higher doses of subcutaneous semaglutide (once weekly at 7.2mg) are being evaluated in phase III clinical trials
When stored correctly, AOD9604 maintains molecular integrity and reproducibility for extended research timelines
We monitor every Liraglutide patient with regular check-ins, dose adjustments, and lab work as needed